Clinical Trials in Colorado

Showing 6941-6960 of 18,143 trials

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

NCT05759208

The objective of this study is to compare the safety and efficacy of OK-101 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Dry Eye Disease

Okyo Pharma Ltd240 participantsStarted Apr 2023

Newport Beach, California, United States • Colorado Springs, Colorado, United States • Louisville, Kentucky, United States +3 more locations

COMPLETEDPhase 150 miles

A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

NCT04887857

The purpose of this study is to evaluate the safety, tolerability, and preliminary efficacy of CC-486 (ONUREG®) in combination with venetoclax in relapsed and/or refractory Acute Myeloid Leukemia (AML) and newly diagnosed AML.

Leukemia, Myeloid, Acute

Celgene6 participantsStarted Dec 2021

Stanford, California, United States • Denver, Colorado, United States • Boston, Massachusetts, United States +7 more locations

TERMINATEDPhase 350 miles

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541

This study looks at the safety and effectiveness of PF-07304814 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either PF-07304814 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H6.

COVID-19

National Institute of Allergy and Infectious Diseases (NIAID)58 participantsStarted Sep 2021

Chula Vista, California, United States • Los Angeles, California, United States • Mather, California, United States +37 more locations

The Study Evaluating the Efficacy and Safety of OK-101 in Subjects With Dry Eye Disease

A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Find Trials by Condition in Colorado

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Registry of CytoSorb Therapy in COVID-19 ICU Patients

Pleconaril Enteroviral Sepsis Syndrome

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

A Study of ABBV-011 Alone and in Combination With Budigalimab (ABBV-181) in Participants With Relapsed or Refractory Small Cell Lung Cancer

Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD

S1313, PEGPH20 in Treating Patients With Newly Diagnosed Metastatic Pancreatic Cancer

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

Actuate 1901: 9-ING-41 in Myelofibrosis

A Pharmacokinetics Study of MK-7655A in Pediatric Participants With Gram-negative Infections (MK-7655A-020)

A Study to Investigate CYC140, in Subjects With Advanced Solid Tumors and Lymphoma

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

Study Comparing Stereotactic Body Radiotherapy vs Conventional Palliative Radiotherapy (CRT) for Spinal Metastases

Safety and Immunogenicity of pDNA Vaccines Expressing HIV M Group p24^Gag Conserved Elements and/or p55^Gag, Administered With IL-12 pDNA